Opendata, web and dolomites

PLUTO SIGNED

One-of-a-kind therapy for crossed eyes. Helping families to reduce emotional and financial burden of eye therapy.

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 PLUTO project word cloud

Explore the words cloud of the PLUTO project. It provides you a very rough idea of what is the project "PLUTO" about.

pediatric    cheap    proposition    doctors    stimulate    sight    outstanding    child    time    fulfilled    competitors    designed    eyes    clinical    made    games    population    vision    lazy    half    untreated    therapies    neuropathic    achievements    effectiveness    environment    children    reducing    started    enjoyable    world       crossed    poland    virtual    price    motion    batch    tailor    covered    shorten    patch    cortex    eye    complete    psychosocial    times    cheaper    full    proving    medicine    scaling    attend    minimized    business    significantly    plan    comfortable    despite    sensors    stationary    primary    stimulation    income    ambylopathy    visual    remmedvr    cerebral    home    trials    create    doctor    six    treatment    months    first    strabismus    vr    sufficient    least    optometry    prototypes    surgery    tracking    ophthalmology    train    commercialization    representative    eliminating    took    standard    therapy    patients    remote    considering    shorter    perception    natural    visits    days   

Project "PLUTO" data sheet

The following table provides information about the project.

Coordinator
REMMEDVR SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA 

Organization address
address: DOMANIEWSKA 41/10
city: WARSZAWA
postcode: 02 672
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Poland [PL]
 Total cost 2˙767˙900 €
 EC max contribution 1˙937˙530 € (70%)
 Programme 1. H2020-EU.3. (PRIORITY 'Societal challenges)
2. H2020-EU.2.3. (INDUSTRIAL LEADERSHIP - Innovation In SMEs)
3. H2020-EU.2.1. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies)
 Code Call H2020-SMEInst-2018-2020-2
 Funding Scheme SME-2
 Starting year 2019
 Duration (year-month-day) from 2019-11-01   to  2021-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    REMMEDVR SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA PL (WARSZAWA) coordinator 1˙937˙530.00

Map

 Project objective

Strabismus (crossed eyes) and ambylopathy (lazy eye) are among the most common eye problems in children, affecting up to 5% of the population. Untreated, they may lead to reduced vision in one/both eyes or even complete loss of sight. Despite the treatment methods offered currently by medicine (surgery, eye patch, stationary vision therapy), the need to of cheap and enjoyable treatment for home use that would significantly shorten therapy time and have sufficient effectiveness has not been fulfilled. At RemmedVR, in collaboration with doctors with outstanding achievements in pediatric ophthalmology from Poland and the EU we took the challenge to create a unique world’s first system designed for remote home use, reducing therapy time from six months to 90 days on average, with minimized doctor visits while eliminating psychosocial impact on the child. RemmedVR’s tracking sensors are also unique among available vision therapies. Advanced motion tracking system makes the perception of virtual reality (VR) environment more natural and comfortable to train visual perception with games designed to stimulate the cerebral cortex for neuropathic stimulation. Considering costs of treatment and shorter therapy duration, RemmedVR is available for at least half the price of standard vision therapy and 4 times cheaper than our competitors. It also allows doctors to attend more patients and increase income. The primary objective of the Phase 2 project is to adopt virtual reality-based technology to optometry needs. Our value proposition is based on objective measurement which can be done only through tailor-made eye tracking and hand tracking sensors. Having a batch of representative prototypes, we have started proving the effectiveness of our system in pre-clinical trials. We further want to test our system in full clinical trials. Other steps covered in this project are related to scaling business and implementation of commercialization plan.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "PLUTO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "PLUTO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.3.;H2020-EU.2.3.;H2020-EU.2.1.)

Click and Spray (2020)

A SIMPLER, CHEAPER AND EASIER TO RECYCLE AEROSOL CONTAINER

Read More  

ERGOVIAkinematix (2018)

New wearable measurement devices for Industry 4.0 based on gaming motion-capture system

Read More  

Primavera (2018)

Primavera: immunobiotics for treating early stage Age-related Macular Degeneration (AMD)

Read More